Wolfpack Investor Network
VC Fund
Raleigh, United States
Wolfpack Investor Network is a VC fund in Raleigh focused on Health Care and B2B. The Wolfpack Investor Network provides an angel investing platform and co-investment fund that leverages the NC State alumni network. Portfolio companies must have an NC State affiliation and be headquartered in the United States.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Wolfpack Investor Network invests in
Stages Wolfpack Investor Network invests in
Countries Wolfpack Investor Network invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
Tom Laundon
|
|||
3 more contacts available
Investment Focus
Industry
- Health Care 3 (25%)
- B2B 2 (17%)
- Medical 2 (17%)
- Software 2 (17%)
- Biotechnology 2 (17%)
Stage
- Seed 4 (33%)
- Series A 4 (33%)
- Pre-Seed 1 (8%)
- Series B 1 (8%)
- Series C 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Sharat Nagaraj
Private Investor
|
Private Investor | Total investments: 0 | Find email | |
|
Tom Laundon
Member
|
Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
VQ Biomedical is developing a revolutionary, minimally invasive catheter that delivers supplemental oxygen directly into the bloodstream in hospitalized patients with respiratory failure. | $1.7M / Seed / Mar 27, 2025 | |
|
|
Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industryluminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. | $4M / Series A / Oct 27, 2022 | |
|
|
SaaS software and services for virtual and hybrid events, meetings, and communal experiences. | $540K / Pre-Seed / Oct 10, 2022 | |
|
|
Biospatial is a company building a national collaborative to provide early warning of health events and trends. The company's mission is to build a national network of data partners and operational users to support public health preparedness, enable an informed emergency response, and strengthen national security.Founded in 2017, Biospatialis headquartered in Durham, North Carolina. | $3.4M / Series A / Mar 28, 2022 | |
|
|
Spiffy is the all-in-one mobile service enablement platform built for franchise car dealerships. We power turnkey on-site oil changes, detailing, tires, and car washes—helping dealers capture high-margin fixed ops revenue, strengthen customer retention, and scale mobile service across their network. Founded in 2014 and headquartered in Apex, NC,Spiffy partners with franchise dealership groups across the United States. The platform handles scheduling, dispatch, technician management, and customer communication end-to-end, giving dealerships a fully managed mobile service operation without the overhead. Spiffy has raised $90M to accelerate dealer partnerships and platform growth. | $9M / Series B / Jun 01, 2021 | |
|
|
Second Nature is a consumer goods company that specializes in providing air filters. It offers a web-based platform that enables people to purchase online its services include shipping, installation, and maintenance that helps their client to improve their indoor air quality and protect the HVAC system.The company was founded in 2012 andheadquartered in North Carolina, United States. | $16.4M / Series C / Mar 25, 2020 | |
|
|
Diveplane Corporation is a groundbreaking technology startup dedicated to keeping the humanity in AI. Their first project is an Understandable AI decision system. They believe in Responsible AI, meaning machines ought to preserve, amplify, and empower the best intentions of humanity both in how they function technically, and how they are applied tosolve problems – unlike uninterpretable black box systems that make life-altering decisions in an instant, but can’t explain why.Their proprietary and patented AI platform is faster than current off-the-shelf solutions and can train on significantly less data, while also addressing the technical shortcomings and societal concerns that have kept many from trusting and adopting AI. | $6M / Seed / Oct 16, 2018 | |
|
|
The company's mission focuses on establishing trustworthy AI as the global standard by redesigning it from the ground up, ensuring transparency and human comprehensibility in every aspect.Howso is an AI-driven platform designed to assist enterprises in preparing and analyzing data for AI use cases. This is achieved through the UnderstandableAI® Platform—a data-centric AI solution offering a clear alternative to traditional neural networks.Howso (formerly “Diveplane”) was co-founded by Dr. Mike Capps, Dr. Chris Hazard, and Mike Resnick in 2017. In September 2023, the company rebranded to Howso, alongside the release of our open source project. | Seed / Oct 16, 2018 | |
|
|
Improved Nature is a plant-based company offering a delicious, sustainable, and high-quality meat substitute. It also offers a comforting taste and texture, while providing advanced nutrition with a short and simple all-natural list of ingredients. The company plant-based and meat-free products deliver all the protein and bite of meat, without thefat. Improved Nature product Nature’s PRIME plant-based protein is the simplest and cleanest plant-powered meat alternative on the market with a complete protein with meat-like texture and neutral flavor that can easily replace chicken, beef, or pork. All products are FDA certified and available to restaurants, hospitals, universities, K-12 schools, and institutions everywhere. | $3M / Convertible Note / Sep 18, 2018 | |
|
|
Emergo Therapeutics is a pharmaceutical startup that develops treatment options for flu-like illnesses. It is focused on developing drugs to modulate inflammatory cytokines and improve the functioning of the immune system in various potential indications, starting with infectious diseases. Emergo’s therapeutic interventions are focused on reducingthe production of inflammatory cytokines from mast cells.Emergo is headquartered in Durham, North Carolina. | $12M / Series A / May 23, 2018 | |
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Wolfpack Investor Network invest in?
Wolfpack Investor Network invests primarily in Health Care, B2B and Medical startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wolfpack Investor Network?
Public channels for Wolfpack Investor Network include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wolfpack Investor Network?
The team at Wolfpack Investor Network includes Sharat Nagaraj (Private Investor) and Tom Laundon (Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!